Published in Anticancer Drugs on September 01, 1996
Molecular and therapeutic potential and toxicity of valproic acid. J Biomed Biotechnol (2010) 2.13
Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br J Cancer (2005) 1.19
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report. Clin Cancer Res (2010) 0.99
Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors. Mol Cancer Ther (2009) 0.97
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma. Anticancer Drugs (2012) 0.94
Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma. Neoplasia (2012) 0.93
Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium. Br J Cancer (2007) 0.90
Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Res (2015) 0.81
Valproic acid overcomes hypoxia-induced resistance to apoptosis. Oncol Rep (2011) 0.78
DNA and histone deacetylases as targets for neuroblastoma treatment. Interdiscip Toxicol (2010) 0.77
Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells. Interdiscip Toxicol (2009) 0.77
Valproic acid promotes radiosensitization in meningioma stem-like cells. Oncotarget (2015) 0.76
Sodium valproate facilitates the propagation of granulocytic ehrlichiae (Anaplasma phagocytophilum) in HL-60 cells. Exp Appl Acarol (2002) 0.75
In vitro anticancer drug test: A new method emerges from the model of glioma stem cells. Toxicol Rep (2014) 0.75
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet (1992) 5.59
Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol (1999) 4.74
Molecular mobility and nucleocytoplasmic flux in hepatoma cells. J Cell Biol (1986) 3.48
Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection (1991) 3.29
Treatment of SARS with human interferons. Lancet (2003) 3.10
Combined spatial and temporal imaging of brain activity during visual selective attention in humans. Nature (1994) 2.89
Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25
Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol (2003) 2.22
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol (2001) 2.01
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (2003) 1.88
Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection (2003) 1.78
Neural mechanisms of global and local processing. A combined PET and ERP study. J Cogn Neurosci (1998) 1.76
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Comparison between sheep and human cervical spines: an anatomic, radiographic, bone mineral density, and biomechanical study. Spine (Phila Pa 1976) (2001) 1.65
Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy (2002) 1.59
RBE for carbon track-segment irradiation in cell lines of differing repair capacity. Int J Radiat Biol (1999) 1.54
The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. Eur J Cancer (2001) 1.54
Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 1.51
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. Cell Death Dis (2011) 1.51
Bedside assessment of cerebral blood flow by double-indicator dilution technique. Anesthesiology (2000) 1.48
Hypoxic reoxygenation during initial reperfusion attenuates cardiac dysfunction and limits ischemia-reperfusion injury after cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg (2009) 1.47
Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43
Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology (1998) 1.43
Puerperal development of ewes following dystocia: a retrospective analysis of two approaches to caesarean section. Vet Rec (2013) 1.41
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol (2010) 1.36
Correction methods for three-dimensional reconstructions from confocal images: I. Tissue shrinking and axial scaling. J Neurosci Methods (2000) 1.34
Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol (2000) 1.31
Automatic segmentation of thoracic and pelvic CT images for radiotherapy planning using implicit anatomic knowledge and organ-specific segmentation strategies. Phys Med Biol (2008) 1.31
An influenza A H1N1 virus revival - pandemic H1N1/09 virus. Infection (2009) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut (2005) 1.24
Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol (2001) 1.23
Deconvolution of event-related fMRI responses in fast-rate experimental designs: tracking amplitude variations. J Cogn Neurosci (2000) 1.23
Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis. Exp Clin Endocrinol Diabetes (2001) 1.22
Comparison of BMP-2 and combined IGF-I/TGF-ss1 application in a sheep cervical spine fusion model. Eur Spine J (2002) 1.21
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J Virol Methods (1996) 1.20
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg (1996) 1.19
Human cytomegalovirus replicates in primary human bone marrow cells. J Gen Virol (1986) 1.18
Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transplant (2012) 1.18
The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol (2008) 1.18
Biological imaging of heavy charged-particle tracks. Radiat Res (2003) 1.17
When should prophylactic treatment in patients with haemophilia A and B start?--The German experience. Haemophilia (1998) 1.16
Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods (1995) 1.14
Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant. J Clin Oncol (1994) 1.14
Influenza vaccination compliance among health care workers in a German university hospital. Infection (2008) 1.13
Repair of degraded duplex DNA from prehistoric samples using Escherichia coli DNA polymerase I and T4 DNA ligase. Nucleic Acids Res (1998) 1.11
Common genomic variation in the FER gene: useful to stratify patients with sepsis due to pneumonia? Intensive Care Med (2015) 1.10
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol (1994) 1.10
Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol (2001) 1.09
Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus (1990) 1.09
Stability and inactivation of SARS coronavirus. Med Microbiol Immunol (2005) 1.09
Non-classical light emission from a single electrically driven quantum dot. Opt Express (2007) 1.08
The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol (2001) 1.08
Investigation of mycobacterial recA function: protein introns in the RecA of pathogenic mycobacteria do not affect competency for homologous recombination. Mol Microbiol (1998) 1.08
Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung (1992) 1.08
Viral zoonoses - a threat under control? Intervirology (2003) 1.07
Rapid diagnosis of enterovirus infection by a new one-step reverse transcription-PCR assay. J Clin Microbiol (1997) 1.06
Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children. AIDS (1999) 1.06
Prions and orthopedic surgery. Infection (2003) 1.06
Measurement of intracellular dna double-strand break induction and rejoining along the track of carbon and neon particle beams in water. Int J Radiat Oncol Biol Phys (1996) 1.05
Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology (1996) 1.05
A multivariate, spatiotemporal analysis of electromagnetic time-frequency data of recognition memory. Neuroimage (2003) 1.05
Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol (1996) 1.04
Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis. BMC Med Inform Decis Mak (2007) 1.04
Laboratory diagnosis of norovirus: which method is the best? Intervirology (2003) 1.04
Typing and strain differentiation of clinical herpes simplex virus type 1 and 2 isolates by polymerase chain reaction and subsequent restriction fragment length polymorphism analysis. Zentralbl Bakteriol (1994) 1.03
Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion? Curr Drug Targets Infect Disord (2003) 1.03
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm (2007) 1.03
Time since vertebral fracture: an important variable concerning quality of life in patients with postmenopausal osteoporosis. Osteoporos Int (1999) 1.02
The impact of conventional and heavy ion irradiation on tumor cell migration in vitro. Int J Radiat Biol (2007) 1.02
Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (2002) 1.02
Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer (1996) 1.02
Valproic acid for the treatment of pediatric malignant glioma. Klin Padiatr (1999) 1.01
Characterization of CDKN1A (p21) binding to sites of heavy-ion-induced damage: colocalization with proteins involved in DNA repair. Int J Radiat Biol (2002) 1.01
Results of a prospective multicenter study for evaluation of the diagnostic quality of an open whole-body low-field MRI unit. A comparison with high-field MRI measured by the applicable gold standard. Eur J Radiol (1999) 1.00
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro. Mult Scler (2008) 1.00
The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat (2003) 1.00
High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology (2000) 1.00
Comparison of different methods for the detection of rubella-specific IgM antibodies. J Med Virol (1981) 1.00
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ (2006) 1.00